Tumor stroma and regulation of cancer development.
暂无分享,去创建一个
[1] S. M. Saati,et al. Cataloging altered gene expression in young and senescent cells using enhanced differential display. , 1995, Nucleic acids research.
[2] H. Tschesche,et al. Matrix Metalloproteinases Collagenase-2, Macrophage Elastase, Collagenase-3, and Membrane Type 1-Matrix Metalloproteinase Impair Clotting by Degradation of Fibrinogen and Factor XII* , 2000, The Journal of Biological Chemistry.
[3] D. Gabrilovich,et al. Immature myeloid cells and cancer-associated immune suppression , 2002, Cancer Immunology, Immunotherapy.
[4] C. Eng,et al. From developmental disorder to heritable cancer: it's all in the BMP/TGF-β family , 2003, Nature Reviews Genetics.
[5] T. Kupper,et al. Immune surveillance in the skin: mechanisms and clinical consequences , 2004, Nature Reviews Immunology.
[6] S. Pawlowski,et al. Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. , 2002, Cancer research.
[7] L. A. Richards,et al. Increased mast cell density in invasive melanoma , 1998, Journal of cutaneous pathology.
[8] D. Hanahan,et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.
[9] Ash A. Alizadeh,et al. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.
[10] M J Bissell,et al. Tumors are unique organs defined by abnormal signaling and context. , 2001, Seminars in cancer biology.
[11] Steven A. Rosenberg,et al. Adoptive-cell-transfer therapy for the treatment of patients with cancer , 2003, Nature Reviews Cancer.
[12] Mina J Bissell,et al. The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.
[13] A. Gudkov. Microarray Analysis of p53-Mediated Transcription: Mutli-Thousand Piece Puzzle or Invitation to Collective Thinking? , 2003, Cancer biology & therapy.
[14] Ricky T. Tong,et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.
[15] G. Colditz,et al. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. , 1999, The New England journal of medicine.
[16] J. Campisi,et al. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.
[17] J. Masferrer,et al. Celecoxib: a specific COX-2 inhibitor with anticancer properties. , 2002, Cancer control : journal of the Moffitt Cancer Center.
[18] U. Felbor,et al. Generation and degradation of human endostatin proteins by various proteinases , 2000, FEBS letters.
[19] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[20] R. DuBois,et al. The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.
[21] B. Pasche,et al. Is C-reactive protein an inflammation opsonin that signals colon cancer risk? , 2004, JAMA.
[22] R. Grénman,et al. Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro. , 1997, Experimental cell research.
[23] N. Funel,et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma , 2004, Journal of Clinical Pathology.
[24] M. Barcellos-Hoff,et al. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.
[25] A. Churg,et al. Mechanisms in the pathogenesis of asbestosis and silicosis. , 1998, American journal of respiratory and critical care medicine.
[26] J. Gray,et al. The genetics and genomics of cancer , 2003, Nature Genetics.
[27] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[28] F. Fitzpatrick,et al. Inflammation, carcinogenesis and cancer. , 2001, International immunopharmacology.
[29] David Botstein,et al. Systemic and cell type-specific gene expression patterns in scleroderma skin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] G. Salles,et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. , 1998, Blood.
[31] K. Kinzler,et al. Landscaping the Cancer Terrain , 1998, Science.
[32] P. Autio,et al. Collagen synthesis in human skin in vivo: modulation by aging, ultraviolet B irradiation and localization. , 1994, Photodermatology, photoimmunology & photomedicine.
[33] J A Hanley,et al. Nested caseÐcontrol study of the effects of non- steroidal anti-inflammatory drugs on breast cancer risk and stage , 2000 .
[34] H. Moses,et al. Stromal fibroblasts in cancer initiation and progression , 2004, Nature.
[35] J. Samet,et al. Sleep-disordered Breathing and Hypertension: More Research Is Still Needed , 2000 .
[36] L. Coussens,et al. The interplay between innate and adaptive immunity regulates cancer development , 2005, Cancer Immunology, Immunotherapy.
[37] B. Toole,et al. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[38] V. Sukhatme,et al. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. , 1999, Biochemical and biophysical research communications.
[39] F. Balkwill. Cancer and the chemokine network , 2004, Nature Reviews Cancer.
[40] J. Cerhan,et al. Association of aspirin and other non‐steroidal anti‐inflammatory drug use with incidence of non‐hodgkin lymphoma , 2003, International journal of cancer.
[41] K. Alitalo,et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. , 2002, The American journal of pathology.
[42] H. Kojima,et al. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. , 2000, The European respiratory journal.
[43] R. López‐Ridaura,et al. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis , 2003, BMC Cancer.
[44] J. Risteli,et al. Type I collagen turnover and cross-linking are increased in irradiated skin of breast cancer patients. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[45] R. Kalluri,et al. Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth* , 2000, The Journal of Biological Chemistry.
[46] L. Benjamin,et al. Angiogenesis: Tumorigenesis and the angiogenic switch , 2003, Nature Reviews Cancer.
[47] W. Schürch,et al. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[48] R. Kalluri. Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.
[49] R L Juliano,et al. Integrin signaling and cell growth control. , 1998, Current opinion in cell biology.
[50] I. Takanami,et al. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma , 2000, Cancer.
[51] R. Billingham,et al. Transplantation of Skin Components during Chemical Carcinogenesis with 20-Methylcholanthrene , 1951, British Journal of Cancer.
[52] J. Wallace,et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. , 2002, Blood.
[53] Frank McCormick,et al. Cancer: Survival pathways meet their end , 2004, Nature.
[54] J. Quigley,et al. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. , 2001, Blood.
[55] A. Nagler,et al. Halofuginone: a potent inhibitor of critical steps in angiogenesis progression , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] Drew M. Pardoll,et al. Vaccines: Spinning molecular immunology into successful immunotherapy , 2002, Nature Reviews Immunology.
[57] H. Kosmehl,et al. Fibrillary co-deposition of laminin-5 and large unspliced tenascin-C in the invasive front of oral squamous cell carcinoma in vivo and in vitro , 2001, Journal of Cancer Research and Clinical Oncology.
[58] S. Weitzman,et al. Chronic inflammation and cancer. , 2002, Oncology.
[59] L. Coussens,et al. Matrix Metalloproteinases: Mediators of Tumour-Host Cell Interactions , 2005 .
[60] S. Okushiba,et al. Long-term survival after radical resection of advanced pancreatic cancer , 2003, International journal of gastrointestinal cancer.
[61] P. Khavari,et al. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .
[62] P. Carmeliet. Angiogenesis in health and disease , 2003, Nature Medicine.
[63] G. Bratthauer,et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.
[64] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[65] I. Stamenkovic,et al. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. , 2002, Genes & development.
[66] T. Tlsty,et al. Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.
[67] B. Fingleton,et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.
[68] P. Rous,et al. CONDITIONAL NEOPLASMS AND SUBTHRESHOLD NEOPLASTIC STATES , 1941, The Journal of experimental medicine.
[69] S. Jimi,et al. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. , 2000, Human pathology.
[70] M. Aumailley,et al. Structure and biological activity of the extracellular matrix , 1998, Journal of Molecular Medicine.
[71] H. Jick,et al. Association Between Acetaminophen or Nonsteroidal Antiinflammatory Drugs and Risk of Developing Ovarian, Breast, or Colon Cancer , 2002, Pharmacotherapy.
[72] M. Hendrix,et al. Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma , 2003, Nature Reviews Cancer.
[73] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[74] N. Fusenig,et al. Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.
[75] R. Kalluri,et al. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. , 2002, The American journal of pathology.
[76] M J Bissell,et al. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.
[77] A J Bailey,et al. Changes in collagen metabolism in prostate cancer: a host response that may alter progression. , 2001, The Journal of urology.
[78] F. Mitjans,et al. Integrin αVβ3 Promotes M21 Melanoma Growth in Human Skin by Regulating Tumor Cell Survival , 1999 .
[79] P. Szlosarek,et al. Tumour necrosis factor α: a potential target for the therapy of solid tumours , 2003 .
[80] F. Kabbinavar,et al. Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer , 2004, Techniques in Coloproctology.
[81] Shawn M. Sweeney,et al. Mapping the Ligand-binding Sites and Disease-associated Mutations on the Most Abundant Protein in the Human, Type I Collagen* , 2002, The Journal of Biological Chemistry.
[82] S. Weiss,et al. Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.
[83] D. Edwards,et al. Metalloproteinases and their inhibitors in angiogenesis , 2003, Expert Reviews in Molecular Medicine.
[84] D. McDonald,et al. Microvascular Remodelling In Chronic Airway Inflammation In Mice , 2000, Clinical and experimental pharmacology & physiology.
[85] S. Phan,et al. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. , 2001, Current pharmaceutical design.
[86] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[87] Nicholas R. English,et al. Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.
[88] A. van den Hooff,et al. Stromal involvement in malignant growth. , 1988 .
[89] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[90] R. Herbst,et al. Clinical studies of angiogenesis inhibitors: The university of texas md anderson center trial of human endostatin , 2001, Current oncology reports.
[91] T. Oshikiri,et al. Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response , 2003, Journal of surgical oncology.
[92] G. Dranoff. Coordinated tumor immunity , 2003 .
[93] W. Coleman,et al. Age-dependent regulation of the tumorigenic potential of neoplastically transformed rat liver epithelial cells by the liver microenvironment. , 1994, Cancer research.
[94] F. Balkwill. Tumor necrosis factor or tumor promoting factor? , 2002, Cytokine & growth factor reviews.
[95] M. Bissell,et al. Dynamic reciprocity: how do extracellular matrix and hormones direct gene expression? , 1987, Progress in clinical and biological research.
[96] D. McDonald,et al. Significance of blood vessel leakiness in cancer. , 2002, Cancer research.
[97] J. Risteli,et al. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[98] A. Knudson,et al. Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.
[99] M. Bissell,et al. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. , 1995, The Journal of clinical investigation.
[100] Andrew V. Nguyen,et al. The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression , 2002, Journal of Mammary Gland Biology and Neoplasia.
[101] M. Skobe,et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. , 2001, The American journal of pathology.
[102] D. Gabrilovich,et al. Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1 , 2001, The Journal of Immunology.
[103] E. Giovannucci,et al. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[104] S. Takeno,et al. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. , 2003, Oncology reports.
[105] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[106] B. Evers,et al. Inflammation and the development of pancreatic cancer. , 2002, Surgical oncology.
[107] L. Coussens,et al. Three‐Dimensional Visualization of Blood and Lymphatic Vasculature in Tissue Whole Mounts Using Confocal Microscopy , 2005, Current protocols in cytometry.
[108] D. Pinkel,et al. The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.
[109] J. Mössner,et al. Genetic aspects of chronic pancreatitis. , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[110] R. Hynes,et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. , 2003, Cancer cell.
[111] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[112] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[113] G. Colditz,et al. A prospective study of aspirin use and the risk of pancreatic cancer in women. , 2004, Journal of the National Cancer Institute.
[114] L. Coussens,et al. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. , 2005, Cancer cell.
[115] L. Coussens,et al. Extrinsic regulators of epithelial tumor progression: metalloproteinases. , 2000, Current opinion in genetics & development.
[116] D. Hanahan,et al. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. , 1996, The American journal of pathology.
[117] M. Sporn,et al. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. , 1990, Science.
[118] R. M. Hicks,et al. Epithelial-stromal interactions in normal and chemical carcinogen-treated adult bladder. , 1977, Cancer research.
[119] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[120] A. Schor,et al. Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics. , 1988, Journal of cell science.
[121] R. Kaaks,et al. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[122] Michael Karin,et al. IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.
[123] J. Risteli,et al. Aberrant type I and type III collagen gene expression in human breast cancer in vivo , 1998, The Journal of pathology.
[124] H. Maeda,et al. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. , 1998, Biochemistry. Biokhimiia.
[125] J. Risteli,et al. Immunohistochemical study of type I collagen and type I pN‐collagen in benign and malignant ovarian neoplasms , 1995, Cancer.
[126] M J Bissell,et al. Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. , 2000, Endocrine-related cancer.
[127] D. Hanahan,et al. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice , 1994, Journal of virology.
[128] C. Kielty,et al. The Collagen Family: Structure, Assembly, and Organization in the Extracellular Matrix , 2003 .
[129] N F Boyd,et al. Growth factors and stromal matrix proteins associated with mammographic densities. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[130] Lisa M. Ebert,et al. A Skin-selective Homing Mechanism for Human Immune Surveillance T Cells , 2004, The Journal of experimental medicine.
[131] L. Coussens,et al. Inflammation and cancer , 2002, Nature.
[132] S. Cingarlini,et al. Derangement of immune responses by myeloid suppressor cells , 2004, Cancer Immunology, Immunotherapy.
[133] Richard O Hynes,et al. Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.
[134] D. Ruiter,et al. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. , 2001, Investigative Ophthalmology and Visual Science.
[135] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[136] T. Hsu,et al. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[137] L. Coussens,et al. Inflammation and matrix metalloproteinases: implications for cancer development , 2004 .
[138] Matthew Meyerson,et al. Somatic alterations in the human cancer genome. , 2004, Cancer cell.
[139] Peter C. Brooks,et al. New Functions for Non-collagenous Domains of Human Collagen Type IV , 2000, The Journal of Biological Chemistry.
[140] R. Johnson,et al. Angiogenesis: the role of the microenvironment in flipping the switch. , 2001, Current opinion in genetics & development.
[141] L. Benítez-Bribiesca,et al. The Role of Mast Cell Tryptase in Neoangiogenesis of Premalignant and Malignant Lesions of the Uterine Cervix , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[142] A. Nagler,et al. Growth inhibition of prostate cancer xenografts by halofuginone * † , 2002, The Prostate.
[143] Y. Kawarada,et al. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[144] Koichi Yamazaki,et al. CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non‐small cell lung cancers , 2003, Cancer science.
[145] H. Adami,et al. Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.
[146] A. Rademaker,et al. Stimulation of urinary bladder tumorigenesis by carcinogen-exposed stroma. , 1990, The Journal of urology.
[147] D. Elder,et al. Melanoma-stroma interactions: structural and functional aspects. , 2002, The Lancet. Oncology.
[148] R. Weichselbaum,et al. Anti-angiogenic cues from vascular basement membrane collagen. , 2000, Cancer research.
[149] B. Gold,et al. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. , 2000, Annual review of microbiology.
[150] K. Alitalo,et al. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis , 2000, Oncogene.
[151] R K Jain,et al. Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.
[152] Raghu Kalluri,et al. Cancer without disease , 2004, Nature.
[153] Robert J. Moore,et al. An Anti-Tumor Necrosis Factor-α Antibody Inhibits the Development of Experimental Skin Tumors , 2003 .
[154] D. Hanahan,et al. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.
[155] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[156] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[157] Y. Ben-Neriah,et al. NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.
[158] K. O'Byrne,et al. Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. , 2002, Advances in cancer research.
[159] S. Tsao,et al. Sex hormone-induced mammary carcinogenesis in female Noble rats: Expression of TGF-β1 and its receptors, TGF-α, and EGF-R in mammary carcinogenesis , 1999, Breast Cancer Research and Treatment.
[160] L. G. García Rodríguez,et al. Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs , 2001, Epidemiology.
[161] R. Greenblatt,et al. Functional Attributes of Mucosal Immunity in Cervical Intraepithelial Neoplasia and Effects of HIV Infection , 2004, Cancer Research.
[162] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[163] C. Shea,et al. Mast cells in angiolipomas and hemangiomas of human skin: are they important for angiogenesis? , 1994, Journal of cutaneous pathology.
[164] Sophie Lelièvre,et al. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.
[165] L. Hansson,et al. Aspirin and risk for gastric cancer: a population-based case–control study in Sweden , 2001, British Journal of Cancer.
[166] Jane Sottile,et al. Regulation of angiogenesis by extracellular matrix. , 2004, Biochimica et biophysica acta.
[167] M. Shibuya,et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.
[168] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[169] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[170] M. Cotterchio,et al. Nonsteroidal anti-inflammatory drug use and breast cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[171] Y. Matsuzaki,et al. Effect of mast cells on tumor angiogenesis in lung cancer. , 2000, The Annals of thoracic surgery.
[172] T. Tlsty,et al. Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.
[173] L. Coussens,et al. Early neoplastic progression is complement independent. , 2004, Neoplasia.
[174] C. Berking,et al. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. , 2001, Cancer research.
[175] R. Pierce,et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. , 1998, Journal of immunology.
[176] Ivan Stamenkovic,et al. Functional structure and composition of the extracellular matrix , 2003, The Journal of pathology.
[177] P. Hein,et al. Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.
[178] H. Moses,et al. Tumor-stroma interactions. , 2005, Current opinion in genetics & development.
[179] L. Meisner,et al. A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. , 1997, Gastroenterology.
[180] J. Folkman,et al. Fundamental concepts of the angiogenic process. , 2003, Current molecular medicine.
[181] P. Rous,et al. THE EXPERIMENTAL DISCLOSURE OF LATENT NEOPLASTIC CHANGES IN TARRED SKIN , 1941, The Journal of experimental medicine.
[182] R. A. Willis. The unusual in tumour pathology. , 1967, Canadian Medical Association journal.
[183] D. Albertson,et al. Chromosome aberrations in solid tumors , 2003, Nature Genetics.
[184] K. Cullen,et al. Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors , 1998, Breast Cancer Research and Treatment.
[185] E. Vuorio,et al. The family of collagen genes. , 1990, Annual review of biochemistry.
[186] R. Kalluri,et al. Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane* , 2000, The Journal of Biological Chemistry.
[187] M. Pines,et al. Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats. , 2002, Journal of hepatology.
[188] R. DuBois,et al. Cyclooxygenase-2: a therapeutic target. , 2002, Annual review of medicine.
[189] L. Coussens,et al. Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment. , 2002, Differentiation; research in biological diversity.
[190] Elaine Fuchs,et al. Getting under the skin of epidermal morphogenesis , 2002, Nature Reviews Genetics.
[191] C. Morrison,et al. Combined Total Genome Loss of Heterozygosity Scan of Breast Cancer Stroma and Epithelium Reveals Multiplicity of Stromal Targets , 2004, Cancer Research.
[192] L. Aaltonen,et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. , 1998, Science.
[193] P. Muti. The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence. , 2005, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[194] A. Howell,et al. Occurrence of a fetal fibroblast phenotype in familial breast cancer , 1986, International journal of cancer.
[195] Masahiro Inoue,et al. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.
[196] T. Oshikiri,et al. Clinical significance of immune cell infiltration within gallbladder cancer , 2003, British Journal of Cancer.
[197] C. Jackson,et al. Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium. , 1991, Experimental cell research.
[198] M. Herlyn,et al. Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells1 , 2001, The Journal of Immunology.
[199] Saroja Ramanujan,et al. Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. , 2002, Biophysical journal.
[200] R. Kalluri,et al. Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties* , 2000, The Journal of Biological Chemistry.
[201] D. Hanahan,et al. MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.
[202] M. Thun,et al. Inflammation and cancer: an epidemiological perspective. , 2004, Novartis Foundation symposium.
[203] R. D. de Waal,et al. Lymphangiogenesis in malignant tumours: does it occur? , 2001, The Journal of pathology.
[204] R. D. de Waal,et al. Pathophysiological implications of stroma pattern formation in uveal melanoma , 2003, Journal of cellular physiology.
[205] Krieg,et al. Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma? , 1998, The British journal of dermatology.
[206] J. Nyhus,et al. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. , 2002, Cancer research.
[207] D. Pardoll. T cells take aim at cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[208] B. Hogan,et al. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[209] D. Pardoll,et al. Does the immune system see tumors as foreign or self? , 2003, Annual review of immunology.
[210] M. Gleave,et al. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. , 1991, Cancer research.
[211] T. McGaha,et al. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism. , 2002, Arthritis and rheumatism.
[212] L. Coussens,et al. The tumor microenvironment: a critical determinant of neoplastic evolution. , 2003, European journal of cell biology.
[213] Hans Clevers,et al. At the Crossroads of Inflammation and Cancer , 2004, Cell.
[214] M. Sporn,et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[215] L. Coussens,et al. Cancer: An inflammatory link , 2004, Nature.
[216] A. Eisen,et al. Enhanced collagenase production by fibroblasts derived from human basal cell carcinomas. , 1979, Cancer research.
[217] D. Bar-Sagi,et al. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.
[218] D. Ruiter,et al. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. , 2002, Investigative ophthalmology & visual science.
[219] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[220] J. Samet. Does idiopathic pulmonary fibrosis increase lung cancer risk? , 2000, American journal of respiratory and critical care medicine.
[221] T. McGaha,et al. Effect of Halofuginone on the Development of Tight Skin (TSK) Syndrome , 2002, Autoimmunity.
[222] Y. Wong,et al. Sex hormone‐induced prostatic carcinogenesis in the Noble rat: The role of insulin‐like growth factor‐1 (IGF‐1) and vascular endothelial growth factor (VEGF) in the development of prostate cancer , 1998, The Prostate.
[223] Markku Santala,et al. Type I and Type III Collagen Metabolites as Predictors of Clinical Outcome in Epithelial Ovarian Cancer , 1999 .